Skip to main content
Figure 3 | BMC Urology

Figure 3

From: A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study

Figure 3

Inhibition of uroplakin III (UPIII) expression in CBA/J/Hsd mouse bladders following treatment with as -APF. Bladder sections from mice treated with as-APF following bladder epithelial injury show decreased UPIII immunofluorescence staining as compared to mice treated with PBS or inactive control nonglycosylated peptide. A) 7 days of as- APF treatment; B) 21 days of as- APF treatment. Representative data shown for the 3 mice in each treatment group from one experiment; experiment performed three times. (200X final magnification).

Back to article page